|1.||Berger, Martin R: 8 articles (07/2014 - 02/2004)|
|2.||Fisher, Larry W: 7 articles (04/2010 - 06/2004)|
|3.||Moe, Sharon M: 7 articles (11/2006 - 02/2002)|
|4.||Bäuerle, Tobias: 5 articles (06/2012 - 06/2005)|
|5.||Ogata, Yorimasa: 5 articles (01/2011 - 01/2004)|
|6.||Fedarko, Neal S: 5 articles (06/2008 - 06/2004)|
|7.||Bellahcène, A: 5 articles (02/2008 - 05/2000)|
|8.||Chen, Neal X: 5 articles (11/2006 - 02/2002)|
|9.||Wang, Shuang: 4 articles (01/2011 - 03/2010)|
|10.||Wang, Zhitao: 4 articles (01/2011 - 03/2010)|
|1.||Neoplasm Metastasis (Metastasis)
04/01/2011 - "Serum bone sialoprotein levels and bone metastases."
01/01/2011 - "The purpose of this study was to evaluate the diagnostic and prognostic significance of serum bone sialoprotein (BSP) in patients with bone metastasis (BM) from non-small cell lung cancer (NSCLC). "
01/01/2003 - "The present study was conducted to determine the effects of bone sialoprotein (BSP) in promoting vascular invasion of tumor cells in metastasis. "
07/30/2014 - "Increased bone sialoprotein (BSP) serum levels are related to breast cancer skeletal metastasis, but their relevance is unknown. "
07/30/2014 - "Sustained conditional knockdown reveals intracellular bone sialoprotein as essential for breast cancer skeletal metastasis."
|2.||Breast Neoplasms (Breast Cancer)
02/01/2011 - "[Inhibitory effect of bone sialoprotein silencing on the adhesion ability of breast cancer cells to bone matrix]."
08/22/1996 - "Our data show that bone sialoprotein expression in breast cancer is associated with poor prognosis. "
08/22/1996 - "Expression of bone sialoprotein in primary human breast cancer is associated with poor survival."
08/01/1996 - "The recent demonstration that bone sialoprotein (BSP) can be detected in human breast cancer tissue by immunoperoxidase suggests that this phosphoprotein is ectopically expressed by malignant mammary epithelial cells. "
05/01/1996 - "Our recent demonstration that human breast cancer cells express bone sialoprotein (BSP), a bone matrix protein, provides a possible clue for the selective affinity of breast cancer cells for bone. "
01/01/2006 - "However, BAP correlates with bone pain, lytic lesions, and fractures in quite a few studies of MM. Novel markers, such as bone sialoprotein, receptor activator of nuclear factor-kappa B ligand (RANKL), osteoprotegerin, osteopontin, dickkopf-1, and soluble Frizzle-related protein-2 have been found of value in assessing bone lytic disease in MM, but their promising results must be confirmed in large trials. "
|4.||Prostatic Neoplasms (Prostate Cancer)
11/01/2011 - "In this study, a promising conditionally replicating adenovirus (CRAd) driven by a tissue specific bone sialoprotein promoter in controlling prostate cancer both in vitro and in vivo is demonstrated. "
11/01/2011 - "Conditionally replicating adenovirus therapy utilizing bone sialoprotein promoter (Ad-BSP-E1a) in an in vivo study of treating androgen-independent intraosseous prostate cancer."
08/15/2009 - "Bone sialoprotein stimulates focal adhesion-related signaling pathways: role in migration and survival of breast and prostate cancer cells."
04/01/2008 - "Bone sialoprotein is also expressed in breast, lung, thyroid and prostate cancers. "
07/01/1998 - "Prognostic value of bone sialoprotein expression in clinically localized human prostate cancer."
01/01/2013 - "Bone sialoprotein (BSP) has been implicated in a variety of physiological and pathophysiological events, including tumor cell invasion, bone homing, adhesion, and matrix degradation. "
06/03/2008 - "Bone sialoprotein (BSP) is a secreted glycophosphoprotein normally restricted in expression to skeletal tissue that is also induced by multiple neoplasms in vivo. "
02/01/2008 - "Bone sialoprotein (BSP) expression is detected in a variety of human osteotropic cancers. "
02/01/2006 - "Osteoclast number was comparable in both genotypes, and the expression of bone sialoprotein was similar in tumor-bearing bones of both genotypes, excluding two potential mechanisms of overriding the defect. "
11/18/2005 - "Bone sialoprotein (BSP), a major protein in the extracellular matrix of bone, is expressed almost exclusively by bone cells and by cancer cells that have a propensity to metastasize to bone. "
|6.||Collagen Type I (Type I Collagen)
|7.||ruberythric acid (AlP)
|9.||Bone Morphogenetic Protein 6
|10.||Prostate-Specific Antigen (Semenogelase)
|2.||Blood Component Removal (Apheresis)